louisbrulenaudet/clinical-trials huggingface dataset:
Clinical trial NCT00572247: The Psychiatric Rehabilitation Approach to Weight Loss
Official title: The Intervention Involves Education on Nutrition and Physical Activity. Outcomes Evaluate Changes in BMI.
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Schizophrenic Disorders
Lead sponsor: University of Kansas Medical Center
Sponsor class: OTHER
Collaborators: name: National Institute of Mental Health (NIMH)
First posted: 2007-12-13
Enrollment: 133
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL

Brief summary: The primary aim of the project is to examine the efficacy of the Psychiatric Rehabilitation Weight Loss program in reduction of weight and body mass index (BMI.

Detailed description: The study involves 144 individuals who will be randomly assigned to the intervention group or treatment as usual group(control group). All Participants will undergo baseline assessment, assessment at week 12, week 24 and in year from baseline.

Eligibility criteria: Inclusion Criteria:

* A diagnosis of serious mental illness,
* Age 18 - 65
* BMI \> 25
* Medication stable (there have been no changes in antipsychotic medications or mood stabilizers for the last 3 months).

Exclusion Criteria:

* Current or history of eating disorder
* Pregnant or breast feeding
* Uncontrolled HTN
* Severe coronary artery disease
* Severe valvular disease
* Uncontrolled diabetes
* Sustained arrhythmia
* Insulin using severe physical limitations
* Severe Lung Disorders
* Diagnosis of MR or dementia

Primary outcomes:
measure: The reduction of weight and Body Mass Index (BMI)
timeFrame: Week 12, Week 24, 1 Year from Baseline Visit
Secondary outcomes:
measure: Measure of waist circumference, health promotion practices, dietary intake assessment of physical activity
timeFrame: Baseline, 12 Weeks, 24 weeks, 1 year
Other outcomes:
Locations:
city: Kansas City
country: United States
facility: University of Kansas Medical Center
state: Kansas
Study officials:
affiliation: University of Kansas Medical Center
name: Edna Hamera, PhD, RN, CS
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT04875247: IOLMASTER 700 Central Topography Workflow Study.
Official title: IOLMASTER 700 Central Topography Workflow Study.
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Cataract
Lead sponsor: OFTALVIST (Oftalmología Vistahermosa S.L)
Sponsor class: INDUSTRY
First posted: 2021-05-06
Enrollment: 100
Sex: ALL
Minimum age (years): 50
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients older than 50 years with cataracts that have to undergo a cataracts surgery.

Brief summary: The use of ocular biometers like IOLMaster 700, is a common practice to identify several ocular parameters such as the keratometry of the cornea and the axial length of the eye, which are necessary for calculating the power of the intraocular lens in cataract surgery. However, the additional use of other devices, such as Cassini and Pentacam is used to obtain more information of the central topography of the eye. Recently, a new version of the IOLMaster 700 equipment that provides much more detailed information than in its previous version has been presented. The objective of this study is to measure the time that the new IOLMaster 700 takes to perform these measurements of the central topography and compare it with the time it takes using the central topography using the standard IOLMaster 700 version with Cassini on one hand and Pentacam on the other.

It is hypothesized that the use of the new version of the IOLMaster 700 equipment alone can reduce the time of measurements and improve the clinic workflow.


Eligibility criteria: Inclusion Criteria:

* Patients that have to undergo a cataract surgery
* Patients older than 50 years.

Exclusion Criteria:

* Patients that have already undergone a previous corneal surgery.
* Patients suffering from keratoconus.
* Patients exhibiting corneal scars
* Patients exhibiting pterygium

Primary outcomes:
measure: Time needed to do the measurements with each equipment
timeFrame: 1 day (Cataract pre-surgery visit)
Secondary outcomes:
measure: Central topography
timeFrame: 1 day (Cataract pre-surgery visit)
Other outcomes:
Locations:
city: Jeréz de la Frontera
country: Spain
facility: OFTALVIST (Oftalmología Vistahermosa S.L.)
state: Cádiz
Study officials:
affiliation: OFTALVIST (Oftalmología Vistahermosa S.L)
name: Ramón Ruiz Mesa., Doctor
role: PRINCIPAL_INVESTIGATOR
References:
citation: Ruiz-Mesa R, Ruiz-Santos M, Blanch-Ruiz J, Jimenez-Nieto A. Acquisition Time for Swept-Source Optical Biometry Plus Corneal Power Measurement During Cataract Evaluation. Clin Ophthalmol. 2022 Mar 5;16:661-668. doi: 10.2147/OPTH.S351845. eCollection 2022.
Clinical trial NCT03733977: The Reliability And Validity Of Family Satisfaction In Intensive Care Unit 24 (FS-ICU 24) Scale In Turkish Language
Official title: The Reliability And Validity Of Family Satisfaction In Intensive Care Unit 24 (FS-ICU 24) Scale In Turkish Language And The Evaluation Of ICU Patients' Relatives Satisfaction :An Observational Study
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Family Satisfaction
Keywords: Family
Intensive Care Unit
Quality Of Care
Satisfaction
Lead sponsor: TC Erciyes University
Sponsor class: OTHER
First posted: 2018-11-07
Enrollment: 369
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: OTHER
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Family members of intensive care unit patients at least 48 hours hospitalization.

Brief summary: Purpose of this study was to investigate the validity and reliability of Family Satisfaction in the Intensive Care Unit-24 (FC-ICU 24) survey in Turkish language, evaluation the satisfaction of intensive care unit patients' relatives and to determine the factors affecting satisfaction.

Detailed description: Family Satisfaction in the Intensive Care Unit-24 (FC-ICU 24) survey is valid and reliable survey which was used to evaluate family satisfaction of intensive care units.

Turkish version which was prepared based on FS-ICU 24 survey was applied to the relatives of ICU patients (the ICUs in Anesthesiology, Internal Medicine, General Surgery and Neurosurgery ) in the Erciyes University Medical Faculty. The study was conducted between April and June 2015. The Turkish version was tested for reliability and validity, and it was proven to be reliable and valid. The subjects of the study were relatives of patients that were hospitalized for at least 48 hours, who had visited the patient at least once. Only one relative was included in the study per patient, and the survey was conducted after the required permissions were taken from the related medical departments.

Eligibility criteria: Inclusion Criteria:

* Family member of intensive care unit patient ( at least 48 hours hospitalization) aged at least 18

Exclusion Criteria:

* Rejection of family member

Primary outcomes:
measure: Family Satisfaction in Intensive Care Unit (FS-ICU 24) Survey Validation In Turkish Language
timeFrame: An Average Of 3 Months
Secondary outcomes:
Other outcomes:
Locations:
city: Şanlıurfa
country: Turkey
facility: Sanliurfa Education and Research Hospital
Study officials:
affiliation: Sanliurfa Education and Research Hospital
name: ZEYNEP YUKSEL TURHAN, M.D.
role: PRINCIPAL_INVESTIGATOR
affiliation: ERCIYES UNIVERSITY MEDICAL FACULTY
name: AYNUR AKIN, PROF.
role: STUDY_DIRECTOR
References:
Clinical trial NCT05880277: Diagnostic POCUS of Patellar Tendinopathy in Female Athletes
Official title: Diagnostic Point of Care Ultrasound of Patellar Tendon in Female Collegiate Athletes
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Patellofemoral Disorder
Keywords: POCUS
Lead sponsor: Youngstown State University
Sponsor class: OTHER
First posted: 2023-05-30
Enrollment: 20
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 25
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: female collegiate jumping athletes
Primary purpose: DIAGNOSTIC

Brief summary: Purpose: The purpose of this study is to determine the clinical effectiveness of point-of-care diagnostic ultrasound in the assessment of patellar tendon pathologies

Detailed description: Participants will receive information about the study and informed consent will be provided. Participants will voluntarily agree to be a participant in the study. Participants will sign the informed consent, and complete the POCUS demographic information sheet, if they qualify then they will have both of their patellar tendons examined through the use of the Butterfly IQ diagnostic ultrasound. Following the examination, they will complete the Knee Injury and Osteoarthritis Outcome Score (KOOS) and the Knee Injury and Osteoarthritis Outcome Patellofemoral subscale (KOOS-PF) and then complete the study.

Eligibility criteria: Inclusion Criteria:

* 18-25 yr. old female student-athletes who participate in jump-centric activities

Exclusion Criteria:

* anyone who does not fit the inclusion criteria (18-25 yr old female student-athletes who participate in jump-centric activities

Primary outcomes:
measure: Changes of patellar tendons in jumping athletes
timeFrame: 2 years
measure: KOOS
timeFrame: 2 years
Secondary outcomes:
Other outcomes:
Locations:
city: Youngstown
country: United States
facility: Youngstown State University
state: Ohio
Study officials:
affiliation: Faculty
name: Morgan C Bagley, PhD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT06930677: Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200
Official title: A Prospective, Single-arm, Multinational, Multi-center, Clinical Study to Evaluate the Performance and Safety of Musculoskeletal Embolization Using NBGM200 in Patients With Knee Degenerative Osteoarthritis
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Knee Osteoarthritis (Knee OA)
Lead sponsor: Next Biomedical Co., Ltd.
Sponsor class: INDUSTRY
First posted: 2025-04-16
Enrollment: 72
Sex: ALL
Minimum age (years): 50
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: Study in patients with knee osteoarthritis treated by embolization using NBGM200


Eligibility criteria: Inclusion Criteria:

* Osteoarthritis proven by MR-imaging

Exclusion Criteria:

* Current local infection
* Life expectancy less than 6 months

Primary outcomes:
measure: Knee Injury and Osteoarthritis Outcome score (KOOS-12)
timeFrame: 6 months post treatment
Secondary outcomes:
measure: Visual Analog Scale(VAS)
timeFrame: 6 months post treatment
measure: Whole Organ Magnetic Resonance Imaging Score (WORMS)
timeFrame: 6 months post treatment
Other outcomes:
Locations:
city: Ghent
country: Belgium
facility: University Hospital Ghent
city: Leuven
country: Belgium
facility: Uz Leuven
city: Tilburg
country: Netherlands
facility: Elisabeth-Tweesteden Hospital
Study officials:
References:
Clinical trial NCT05741177: Lung Ultrasound in Bronchiolitis
Official title: Studio Osservazionale, Prospettico, Multicentrico, No-profit Sull' utilità Dell' ECOgrafia Pleuro-polmonare Nella Gestione Delle BRONchioliti Nella Popolazione Pediatrica di età ≤12 Mesi - ECO-BRON
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Bronchiolitis
Lead sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sponsor class: OTHER
First posted: 2023-02-23
Enrollment: 300
Sex: ALL
Minimum age (years): 0
Maximum age (years): 12
Standard ages: CHILD
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Inclusion Criteria:

* children with bronchiolitis

Exclusion Criteria:

* children with bronchiolitis and comorbidities

Brief summary: prospective assessment of lung ultrasound score in children with different severities of bronchiolitis


Eligibility criteria: Inclusion Criteria:

* children with bronchiolitis

Exclusion Criteria:

* children with bronchiolitis and comorbidities

Primary outcomes:
measure: lung ultrasound score predict bronchiolitis severity
timeFrame: 1 year
Secondary outcomes:
Other outcomes:
Locations:
city: Rome
country: Italy
facility: Gemelli Hospital
Study officials:
References:
Clinical trial NCT00781677: Using Neuroimaging to Investigate Major Depressive Disorder
Official title: Using Neuroimaging to Investigate Neurobiological Correlates of Treatment Resistance Associated With Co-morbid Anxiety in Major Depressive Disorder
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Major Depressive Disorder
Depression
Anxiety
Keywords: Major Depressive Disorder
Depression
Anxiety
Lead sponsor: University of Texas Southwestern Medical Center
Sponsor class: OTHER
First posted: 2008-10-29
Enrollment: 14
Sex: ALL
Minimum age (years): 18
Maximum age (years): 50
Standard ages: ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: community sample

Brief summary: The purpose of this neuroimaging study is to investigate the brain correlates of Major Depressive Disorder with anxiety symptoms as well as potentially identify predictors of treatment outcome.

Detailed description: The purpose of this study is to test whether the structural and functional connectivity between the dorso-lateral prefrontal cortex (DLPFC) and amygdala will decline as symptoms of co-morbid anxiety (Anxiety Factor Score) increase in patients with MDD. This decrease in connectivity will also account for decrease in treatment response. The structural connectivity will be assessed using Diffusion Tensor Imaging (DTI) and the functional connectivity will be assessed using resting state BOLD fMRI.We propose to use the fMRI and DTI to identify biological markers that are associated with treatment response in a cohort of patients with a spectrum of Anxiety Factor Scores.

Eligibility criteria: Inclusion Criteria:

* Competent to give informed consent
* Diagnosis of Major Depressive Disorder
* Males and females
* Ages 18-50 years old
* All races and ethnicities
* Able to read, speak, and understand English\*

Exclusion Criteria:

* History of psychiatric illness except Major Depressive Disorder, Generalized Anxiety Disorder, Social Phobia, or Specific Phobia
* Alcohol or substance abuse within the last 6 months or alcohol or substance dependence within the last year
* Diagnosis of an organic brain disease
* Serious unstable medical illness
* History of serious head injury
* Unsafe or unable to have an MRI or previous inability to tolerate MRI
* Pregnancy or breast feeding

Primary outcomes:
measure: Treatment response-the Quick Inventory of Depressive Symptomatology: Clinician Rated (QIDS-SR)
timeFrame: 8 weeks
Secondary outcomes:
measure: Degree of comorbid anxiety-a subset of the Hamilton Rating Scale for Depression will be used to determine the anxiety/somatization factor scores
timeFrame: 8 weeks
Other outcomes:
Locations:
city: Dallas
country: United States
facility: University of Texas Southwestern Medical Center
state: Texas
Study officials:
affiliation: University of Texas Southwestern Medical Center
name: Frank A Kozel, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT00983177: Colchicine Treatment for Chronic Shoulder Pain Related to Calcific Tendonitis
Official title: Colchicine Treatment for Chronic Shoulder Pain Related to Calcific Tendonitis: Double Blind Placebo-controlled Study
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Calcific Tendonitis
Lead sponsor: Bnai Zion Medical Center
Sponsor class: OTHER_GOV
First posted: 2009-09-23
Enrollment: 80
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Chronic pain due to calcific tendonitis of shoulder is a prevalent condition usually treated with recurrent courses of NSAIDs, physical therapy or surgical interventions. Colchicine has been reported to be effective in the acute attack of shoulder tendonitis, however, has never been examined in controlled study in patients with chronic shoulder pain secondary to calcific tendonitis. Eighty patients with chronic shoulder pain (at least 3 months duration) due to calcific tendonitis will be randomized to receive colchicine 0.5 mg twice daily or placebo (lactose capsules) for 4 months. At the end of this blinded part of the study, patients who received placebo and did not improve, will be eligible to continue study in the open mode for additional 4 months with study drug. Efficacy (VAS for shoulder pain, shoulder range of motion and shoulder pain and disability index) and safety (blood tests) follow-ups will be scheduled bi-monthly for all patients.


Eligibility criteria: Inclusion Criteria:

* chronic, more than 3 months duration, shoulder pain
* tendinous calcifications on shoulder X-rays

Exclusion Criteria:

* renal insufficiency
* liver insufficiency
* lactose intolerance
* hypersensitivity to colchicine

Primary outcomes:
measure: VAS for shoulder pain
timeFrame: 4-8 months
measure: shoulder range of motion
timeFrame: 4-8 months
measure: shoulder pain and disability index
timeFrame: 4-8 months
Secondary outcomes:
Other outcomes:
Locations:
city: Haifa
country: Israel
facility: Bnai Zion Medical Center
Study officials:
affiliation: Bnai Zion Medical Center
name: Itzhak Rosner, MD
role: STUDY_DIRECTOR
References:
Clinical trial NCT05290077: Role of NGAL in Vitiligo
Official title: Role of Serum NGAL Inearly Detection of CVR in Patients With Vitiligo
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Vitiligo
Keywords: NGAL & CVR
Lead sponsor: Sohag University
Sponsor class: OTHER
First posted: 2022-03-22
Enrollment: 90
Sex: ALL
Minimum age (years): 20
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SCREENING

Brief summary: Role of serum Neutrophil Gelatinase-associated Lipocalin in early detection of cardiovascular risk in patients with Vitiligo


Eligibility criteria: Inclusion Criteria:

* patients with vitiligo above 20y

Exclusion Criteria:

* patients with systemic disease Pregnants female Lactating females Patients less than 20 y Patients with active lesions

Primary outcomes:
measure: serum Neutrophil Gelatinase-associated Lipocalin in patients with Vitilig
timeFrame: 6 months
Secondary outcomes:
Other outcomes:
Locations:
city: Sohag
country: Egypt
facility: Sohag fuculty
Study officials:
References:
citation: Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015 Jul 4;386(9988):74-84. doi: 10.1016/S0140-6736(14)60763-7. Epub 2015 Jan 15.
citation: Vachiramon V, Onprasert W, Harnchoowong S, Chanprapaph K. Prevalence and Clinical Characteristics of Itch in Vitiligo and Its Clinical Significance. Biomed Res Int. 2017;2017:5617838. doi: 10.1155/2017/5617838. Epub 2017 Jul 30.
citation: Silverberg JI, Silverberg NB. Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 2013 Feb;149(2):159-64. doi: 10.1001/jamadermatol.2013.927.
citation: Mazzei Weiss ME. Vitiligo: to biopsy or not to biopsy? Cutis. 2020 Apr;105(4):189-190. No abstract available.
Clinical trial NCT02016677: An Observational Study Exploring the Esthetic Outcomes of Breast Reduction Surgery and /or Mastopexy
Official title: An Observational Study Exploring the Esthetic Outcomes of Breast Reduction Surgery and /or Mastopexy
Study type: OBSERVATIONAL
Overall status: TERMINATED
Conditions: Macromastia
Keywords: Breast reduction
Mastopexy
Sagging
Lead sponsor: Orbix Medical Ltd.
Sponsor class: INDUSTRY
First posted: 2013-12-20
Enrollment: 5
Sex: FEMALE
Minimum age (years): 30
Maximum age (years): 55
Standard ages: ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Female Patients, 30 years of age or older referred for elective breast reduction surgery and /or mastopxy

Brief summary: The purpose of the study is to collect data regarding the aesthetic outcomes of patients who had breast reduction surgery and /or mastopexy in terms such as scaring, patient satisfaction, breast ptosis assessment including taking photographs and filling questionnaires.

Detailed description: This is a prospective observational study, single center cohort to explore the aesthetic outcomes of patients who had breast reduction and / or mastopxy surgery. The surgical intervention will be determined by the clinician with no correlation to this study.

The study will focus on the aesthetic aspects of the clinical outcome resultant from the breast surgery in par course of 5 years. Scar tissue assessment and patient's reported data (satisfaction and well-being) will be collected.

Suitable patients will be assessed for study eligibility at a screening visit and, if eligible, will be scheduled for breast surgery according to the patient and surgeon discretion.

At each follow up visit, patients will undergo clinical general examination, breast and ptosis endearments, scar appearance , aesthetic evaluation. Patients will fill satisfaction questionnaires

Eligibility criteria: Inclusion Criteria:

1. Female patient older than 30 years of age.
2. Patients willing to participate as evidenced by signing the written informed consent.
3. Patient that was found by her physician illegible for breast reduction surgery and /or mastopxy

Exclusion Criteria:

1. Active psychiatric illness, cognitive or sensory impairment. 2. Physical impairment that may prevent filling out a paper and pencil survey or responding to interview questions

-

Primary outcomes:
measure: Measuring the aesthetic outcomes of pre /post- surgical breast ptosis
timeFrame: during 5 years post- surgically
Secondary outcomes:
Other outcomes:
Locations:
city: Tel Aviv
country: Israel
facility: The Plastic Surgery Department The Tel Aviv Sourasky Medical Center
Study officials:
affiliation: TASMC
name: Arik Zaretski, MD
role: STUDY_DIRECTOR
References:
Clinical trial NCT02819245: Impact of Age on Surgical Outcome of Adolescent Idiopathic Scoliosis
Official title: Impact of Age on Surgical Outcome of Adolescent Idiopathic Scoliosis
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Scoliosis
Lead sponsor: Nanjing University School of Medicine
Sponsor class: OTHER
First posted: 2016-06-30
Enrollment: 300
Sex: ALL
Minimum age (years): 10
Maximum age (years): 25
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: This is a study prospectively enrolling adolescent idiopathic scoliosis (AIS) patients and try to find how the age will impact the surgical outcome of AIS.


Eligibility criteria: Inclusion Criteria:

* Adolescent idiopathic scoliosis patients; undergoing posterior correction surgery; with minimum 5 years follow-up; with full-spine radiography.

Exclusion Criteria:

* with spinal tumor; with hip disease; without quality of life measurements.

Primary outcomes:
measure: Improvement of coronal Cobb angle
timeFrame: From immediate post-operative until at least 10 years follow-up
Secondary outcomes:
measure: Improvement of sagittal profile
timeFrame: From immediate post-operative until at least 10 years follow-up
measure: Health-related quality of life (HRQOL)
timeFrame: From immediate post-operative until at least 10 years follow-up
Other outcomes:
Locations:
city: Nanjing
country: China
facility: Nanjing Drum Tower Hospital
state: Jiangsu
Study officials:
affiliation: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
name: Yong Qiu
role: STUDY_CHAIR
References: